Compliance certificate as per regulation 74(5) of SEBI (DP) Regulations 2018.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has submitted a compliance certificate to BSE for the quarter ended 30 September 2025, as required under SEBI's Depositories Regulations. The certificate was issued by the company's Registrar and Share Transfer Agent, Adroit Corporate Services Pvt Ltd, confirming that all dematerialisation requests received from depository participants during the quarter were duly processed and confirmed to the depositories. It also confirms that physical share certificates received for dematerialisation were mutilated, cancelled, and the depository's name was substituted as the registered owner in the company's records within the 15-day timeline.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company's share transfer and dematerialisation processes are running smoothly and in line with SEBI rules.